128 related articles for article (PubMed ID: 37382425)
1. Antisense lncRNA-RP11-498C9.13 promotes bladder cancer progression by enhancing reactive oxygen species-induced mitophagy.
Song W; Li Z; Yang K; Gao Z; Zhou Q; Li P
J Gene Med; 2023 Sep; 25(9):e3527. PubMed ID: 37382425
[TBL] [Abstract][Full Text] [Related]
2. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.
Luo W; Wang J; Xu W; Ma C; Wan F; Huang Y; Yao M; Zhang H; Qu Y; Ye D; Zhu Y
Cell Death Dis; 2021 Nov; 12(11):1043. PubMed ID: 34728613
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
4. The binding of lncRNA RP11-732M18.3 with 14-3-3 β/α accelerates p21 degradation and promotes glioma growth.
Kang CM; Bai HL; Li XH; Huang RY; Zhao JJ; Dai XY; Zheng L; Qiu YR; Hu YW; Wang Q
EBioMedicine; 2019 Jul; 45():58-69. PubMed ID: 31202814
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
6. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
7. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.
Xiao S; Chen J; Wei Y; Song W
Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B.
Li Z; Fu H; Liu J; Song W; Zeng M; Wang J
Pathol Res Pract; 2023 Aug; 248():154635. PubMed ID: 37392551
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer.
Xie J; Ni J; Shi H; Wang K; Ma X; Li W; Peng B
Cancer Med; 2023 Mar; 12(5):5718-5735. PubMed ID: 36208024
[TBL] [Abstract][Full Text] [Related]
11. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
12. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
[TBL] [Abstract][Full Text] [Related]
13. LINC00511 aggravates the malignancy of lung adenocarcinoma through sponging microRNA miR-4739 to regulate pyrroline-5-carboxylate reductase 1 expression.
Ye L; Wang L; Zeng Y
J Clin Lab Anal; 2022 Dec; 36(12):e24760. PubMed ID: 36371775
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.
Xu Y; Zhou W; Zhang C; Liu X; Lv J; Li X; Zhao L; Li W; Li J; Ren Y; Ou R
Int J Biol Macromol; 2019 Jun; 130():24-33. PubMed ID: 30790638
[TBL] [Abstract][Full Text] [Related]
15. LncRNA RP11-214F16.8 drives breast cancer tumorigenesis via a post-translational repression on NISCH expression.
Lv X; Zhang Q
Cell Signal; 2022 Apr; 92():110271. PubMed ID: 35108640
[TBL] [Abstract][Full Text] [Related]
16. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA RP11-909N17.2 presages a poor prognosis of non-small cell lung cancer.
Gao W; Liu T; Tuo Z; Ma L; Zhou Z
Cancer Biomark; 2022; 34(2):211-219. PubMed ID: 34957995
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA RP11-626G11.3 promotes the progression of glioma through miR-375-SP1 axis.
Zhang Y; Mou C; Shang M; Jiang M; Xu C
Mol Carcinog; 2020 May; 59(5):492-502. PubMed ID: 32128886
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
Huang K; Geng J; Wang J
Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
